(3-AMinoMethyl-piperidin-1-yl)-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-Methanone hydrochloride
- $409.32 - $469
- Product name: (3-AMinoMethyl-piperidin-1-yl)-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-Methanone hydrochloride
- CAS: 1353986-22-7
- MF: C15H21ClN2O3
- MW: 312.79184
- EINECS:
- MDL Number:MFCD21098992
- Synonyms:(3-AMinoMethyl-piperidin-1-yl)-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-Methanone hydrochloride;(3-(AMinoMethyl)piperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)Methanone hydrochloride
3 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerAlichem
- Product number1353986227
- Product description(3-(Aminomethyl)piperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanonehydrochloride
- Packaging1g
- Price$409.32
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM156083
- Product description(3-(Aminomethyl)piperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanonehydrochloride 95%
- Packaging1g
- Price$439
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11284490
- Product description(3-(Aminomethyl)piperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanonehydrochloride 95+%
- Packaging1g
- Price$469
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1353986227 | (3-(Aminomethyl)piperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanonehydrochloride | 1g | $409.32 | 2021-12-16 | Buy |
Chemenu | CM156083 | (3-(Aminomethyl)piperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanonehydrochloride 95% | 1g | $439 | 2021-12-16 | Buy |
Crysdot | CD11284490 | (3-(Aminomethyl)piperidin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methanonehydrochloride 95+% | 1g | $469 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|